Literature DB >> 21721113

Clinical predictors of high risk histopathology in retinoblastoma.

Seema Kashyap1, Rachna Meel, Neelam Pushker, Seema Sen, Sameer Bakhshi, Vishnubhatla Sreenivas, Sumita Sethi, Bhavna Chawla, Supriyo Ghose.   

Abstract

BACKGROUND: Previous studies show that clinical features at presentation, in retinoblastoma patients, like glaucoma and neovascularization of iris are associated with a higher incidence of high risk histopathology findings (HRF) in enucleated eyes. Herein, we analyze association between clinical features at time of enucleation and occurrence of HRF including invasion of anterior chamber, iris, ciliary body, choroid (massive), sclera, extrascleral tissue, optic nerve beyond lamina cribrosa, and optic nerve cut end, in a large series of eyes enucleated for retinoblastoma. PROCEDURE: We retrospectively studied demographic, clinical, and histopathology findings in all retinoblastoma patients who underwent primary enucleation at our center, over a 5 years duration. Statistical analysis was done to find any association between clinical features at presentation and the presence of HRF.
RESULTS: Three hundred twenty-six eyes were studied. Median age of presentation was 2 years. Glaucoma was the most common clinical finding at presentation apart from leucocoria. Out of 326 enucleated eyes, 28 (8.6%) had extrascleral and/or optic nerve transection invasion. Among remaining 298 eyes, with completely resected tumor, 115 (38.6%) had massive choroidal invasion, 54 (17%) had retrolaminar optic nerve invasion, and 24 (7%), 29 (9%), and 23(7%) had anterior chamber, iris, and ciliary body invasion, respectively. Age more than 2 years, lag period more than 3 months, hyphema, pseudohypopyon, staphyloma, and orbital cellulitis were associated with occurrence of three or more HRF on univariate analysis.
CONCLUSIONS: Clinical variables including older age, longer lag period, hyphema, pseudohypopyon, staphyloma, and orbital cellulitis were strongly associated with occurrence of HRF in this study.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21721113     DOI: 10.1002/pbc.23239

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  21 in total

1.  Extraocular retinoblastoma in Indian children: clinical, imaging and histopathological features.

Authors:  Sumita Sethi; Neelam Pushker; Seema Kashyap; Sanjay Sharma; Mridula Mehta; Sameer Bakhshi; Saurbhi Khurana; Supriyo Ghose
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

2.  Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.

Authors:  Hans E Grossniklaus
Journal:  Am J Ophthalmol       Date:  2014-07-24       Impact factor: 5.258

Review 3.  Management of retinoblastoma in children: current status.

Authors:  Guillermo Chantada; Paula Schaiquevich
Journal:  Paediatr Drugs       Date:  2015-06       Impact factor: 3.022

4.  Histopathologic grading of anaplasia in retinoblastoma.

Authors:  Pia R Mendoza; Charles S Specht; G Baker Hubbard; Jill R Wells; Michael J Lynn; Qing Zhang; Jun Kong; Hans E Grossniklaus
Journal:  Am J Ophthalmol       Date:  2014-12-19       Impact factor: 5.258

5.  Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.

Authors:  Jesse L Berry; Kaitlin Kogachi; Hassan A Aziz; Kathleen McGovern; Emily Zolfaghari; A Linn Murphree; Rima Jubran; Jonathan W Kim
Journal:  Pediatr Blood Cancer       Date:  2016-11-05       Impact factor: 3.167

6.  Diagnostic delay and sociodemographic predictors of stage at diagnosis and mortality in unilateral and bilateral retinoblastoma.

Authors:  Marco A Ramírez-Ortiz; M Veronica Ponce-Castañeda; M Lourdes Cabrera-Muñoz; Aurora Medina-Sansón; Xinhua Liu; Manuela A Orjuela
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-02-12       Impact factor: 4.254

7.  High-risk histomorphological features in retinoblastoma and their association with p53 expression: An Indian experience.

Authors:  Rao Seema; Sobti Parul; Khurana Nita
Journal:  Indian J Ophthalmol       Date:  2014-11       Impact factor: 1.848

8.  Retinoblastoma major review with updates on Middle East management protocols.

Authors:  Ihab Saad Othman
Journal:  Saudi J Ophthalmol       Date:  2012-04

Review 9.  Retinoblastoma.

Authors:  Helen Dimaras; Timothy W Corson; David Cobrinik; Abby White; Junyang Zhao; Francis L Munier; David H Abramson; Carol L Shields; Guillermo L Chantada; Festus Njuguna; Brenda L Gallie
Journal:  Nat Rev Dis Primers       Date:  2015-08-27       Impact factor: 52.329

10.  Retrospective analysis of primarily treated group D retinoblastoma.

Authors:  Hayyam Kiratli; İrem Koç; Onur Inam; Ali Varan; Canan Akyüz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-30       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.